Periodontitis, Chronic
7
2
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
1 terminated out of 7 trials
66.7%
-19.9% vs benchmark
14%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Impact of Periodontal Inflammation on Allostatic Load
MIST Versus M-MIST for the Treatment of Intrabony Defects
3-Month Clinical Trial of Liquid S-PRF in Periodontal Debridement for Periodontitis Stages II-IV
Assessment of Masticatory Performance in Periodontitis
Effects of Antimicrobial Photodynamic Therapy on Regeneration of Class II Furcation Lesions
Adjunctive Hydrogen Peroxide for Periodontal Therapy
Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction